Severe Combined Immunodeficiency Clinical Trial
Official title:
Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China
Severe combined immunodeficiency (SCID), a rare primary immunodeficiency dieases (PID), is poorly characterized in mainland China. We meant to explore the patients with SCID refered to our hospital and summarize their clinical manifestations and genetic features.
Diagnostic criteria were based on recommendations by the Pan-American Group for Immunodeficiency and the European Society for Immunodeficiencies, which included failure to thrive, persistent diarrhea, respiratory symptoms, and oral candidiasis, or Pneumocystis pneumonia, severe bacterial infections, and disseminated Bacillus Calmette-Guérin (BCG) infection during the first 2 to 7 months of life. In addition, patients included in the study were <2 years of age, with either transplacentally acquired maternal T cells or <20 % CD3+ T cells, the absolute lymphocyte count (ALC) <3000/mm3. Exclusion criteria include HIV infection, congenital rubella, DiGeorge syndrome, Zap70 deficiency, Cartilage hair hypoplasia, PNP deficiency and MHC class II deficiency. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00006335 -
Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID
|
N/A | |
| Active, not recruiting |
NCT03597594 -
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
|
Phase 1/Phase 2 | |
| Completed |
NCT00000603 -
Cord Blood Stem Cell Transplantation Study (COBLT)
|
Phase 2 | |
| Completed |
NCT00001255 -
Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study
|
N/A | |
| Recruiting |
NCT05651113 -
The Experience of Screening for SCID
|
||
| Completed |
NCT00794508 -
MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID
|
Phase 2 | |
| Recruiting |
NCT03538899 -
Autologous Gene Therapy for Artemis-Deficient SCID
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05298930 -
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
|
N/A | |
| Recruiting |
NCT01821781 -
Immune Disorder HSCT Protocol
|
Phase 2 | |
| Completed |
NCT00845416 -
Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population
|
N/A | |
| Terminated |
NCT00006054 -
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
|
N/A | |
| Completed |
NCT03878069 -
Registry Study of Revcovi Treatment in Patients With ADA-SCID
|
||
| Recruiting |
NCT01019876 -
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
|
Phase 2/Phase 3 | |
| Completed |
NCT03513328 -
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT02177760 -
Sirolimus Prophylaxis for aGVHD in TME SCID
|
Phase 2 | |
| Recruiting |
NCT00695279 -
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
|
||
| Completed |
NCT01420627 -
EZN-2279 in Patients With ADA-SCID
|
Phase 3 | |
| Terminated |
NCT02127892 -
SCID Bu/Flu/ATG Study With T Cell Depletion
|
Phase 1/Phase 2 | |
| Completed |
NCT04246840 -
Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow Allograft
|
||
| Completed |
NCT01529827 -
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
|
Phase 2 |